Hello. Sign in to personalize your visit. New user? Register now.  
ICCMR 2010
The Journal of Alternative and Complementary Medicine
Medicinal Benefits of Green Tea: Part II. Review of Anticancer Properties

To cite this article:
Raymond Cooper, D. James Morré, Dorothy M. Morré. The Journal of Alternative and Complementary Medicine. August 2005, 11(4): 639-652. doi:10.1089/acm.2005.11.639.

Full Text: • PDF for printing (101.7 KB) • PDF w/ links (224.8 KB)


Raymond Cooper, Ph.D.
PhytoScience, Inc., Los Altos, CA.
D. James Morré, Ph.D.
Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, IN.
Dorothy M. Morré, Ph.D.
Department of Foods and Nutrition, Purdue University, West Lafayette, IN.

Currently there is wide interest in the medicinal benefits of green tea (Camellia sinensis). Tea is one of the most widely consumed beverages in the world, and extracts of tea leaves are also sold as dietary supplements. Green tea extracts contain a unique set of catechins that possess biologic activity in antioxidant, antiangiogenesis, and antiproliferative assays that are potentially relevant to the prevention and treatment of various forms of cancer. With the increasing interest in the health properties of tea and a significant rise in their scientific investigation, it is the aim of this review to summarize recent findings on the anticancer and medicinal properties of green tea, focusing on the biologic properties of the major tea catechin, (–)-epigallocatechin and its antitumor properties.

Free first page

This paper was cited by:

Case–control study of green tea consumption and the risk of endometrial endometrioid adenocarcinoma
Yukika Kakuta, Naoki Nakaya, Satoru Nagase, Megumi Fujita, Toshimitsu Koizumi, Chikako Okamura, Hitoshi Niikura, Kaori Ohmori, Shinichi Kuriyama, Toru Tase, Kiyoshi Ito, Yuko Minami, Nobuo Yaegashi, Ichiro Tsuji
Cancer Causes & Control. Aug 2009, Vol. 20, No. 5: 617-624
CrossRef
Nondenatured Soy Extracts Reduce UVB-induced Skin Damage via Multiple Mechanisms
Nannan Chen, Richard Scarpa, Li Zhang, Miri Seiberg, Connie B. Lin
Photochemistry and Photobiology. Dec 2008, Vol. 84, No. 6: 1551-1559
CrossRef
Inhibition of mammary tumorigenesis in the C3(1)/SV40 mouse model by green tea
Hoyee Leong, Priya S. Mathur, Geoffrey L. Greene
Breast Cancer Research and Treatment. Mar 2008, Vol. 107, No. 3: 359-369
CrossRef
Productivity and biochemical properties of green tea in response to full-length and functional fragments of HpaGXooc, a harpin protein from the bacterial rice leaf streak pathogen Xanthomonas oryzae pv. oryzicola
Xiaojing Wu, Tingquan Wu, Juying Long, Qian Yin, Yong Zhang, Lei Chen, Ruoxue Liu, Tongchun Gao, Hansong Dong
Journal of Biosciences. Oct 2007, Vol. 32, No. S2: 1119-1131
CrossRef
Tea catechins as a potential alternative anti-infectious agent
Jae Min Song, Baik Lin Seong
Expert Review of Anti-infective Therapy. Jul 2007, Vol. 5, No. 3: 497-506
CrossRef
Green tea polyphenol (?)-epigallocatechin-3-gallate promotes the rapid protein kinaseC- and proteasome-mediated degradation of Bad: implications for neuroprotection
Limor Kalfon, Moussa B. H. Youdim, Silvia A. Mandel
Journal of Neurochemistry. Mar 2007, Vol. 100, No. 4: 992-1002
CrossRef
A Strategy for Controlling Potential Interactions Between Natural Health Products and Chemotherapy
Dugald Seely, Diana Stempak, Sylvain Baruchel
Journal of Pediatric Hematology/Oncology. Feb 2007, Vol. 29, No. 1: 32-47
CrossRef
HPLC Analysis of Catechins, Theaflavins, and Alkaloids in Commercial Teas and Green Tea Dietary Supplements: Comparison of Water and 80% Ethanol/Water Extracts
Mendel Friedman, Carol E. Levin, Suk-Hyun Choi, Etsuko Kozukue, Nobuyuki Kozukue
Journal of Food Science. Sep 2006, Vol. 71, No. 6: C328-C337
CrossRef
Catechin-Vanilloid Synergies with Potential Clinical Applications in Cancer
Dorothy M. Morré, D. James Morré
Rejuvenation Research. Mar 2006, Vol. 9, No. 1: 45-55
Abstract | Full Text PDF | Reprints & Permissions
Current and future status of prostate cancer chemoprevention
Naohiro Fujimoto, Masayoshi Nomura, Tetsuro Matsumoto
Expert Review of Anticancer Therapy. Feb 2006, Vol. 6, No. 1: 59-71
CrossRef
All articles
Previous Next